Retatrutide

Description

Overview

Retatrutide (LY3437943) is a novel triple agonist peptide targeting GIP, GLP-1, and glucagon receptors simultaneously. This represents the latest advancement in multi-receptor incretin research compounds.

Research Applications

• Multi-receptor agonism studies
• Advanced metabolic pathway research
• Energy expenditure investigations
• Comparative incretin studies

Specifications

• Target Receptors: GIP-R, GLP-1R, GCGR
• Purity: ≥99% (HPLC verified)
• Form: Lyophilized powder
• Storage: -20°C, protect from light